Sanofi (SNYN) — Capital Reinvestment Ratio
Latest as of December 2025:
0.33x
Sanofi (SNYN) has a Capital Reinvestment Ratio of 0.33x as of December 2025, meaning it reinvests 0% of its operating cash flow (MX$10.75 Billion) in capital expenditures (MX$3.54 Billion). See Sanofi (SNYN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.33x
Capex / Operating Cash Flow
Operating Cash Flow
MX$10.75 Billion
MXN
Capital Expenditures
MX$3.54 Billion
MXN
Data as of
Dec 2025
Most recent filing
Sanofi Capital Reinvestment Ratio (2013–2025)
This chart tracks Sanofi's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Sanofi (2013–2025)
Year-by-year Capital Reinvestment Ratio for Sanofi from 2013 to 2025. For live market cap and broader valuation context, see Sanofi stock valuation.
| Year | Reinvestment Ratio | Operating CF (MXN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | MX$10.75 Billion | MX$3.54 Billion | ▼ -6.5% |
| 2024 | 0.35x | MX$9.08 Billion | MX$3.19 Billion | ▲ +19.3% |
| 2023 | 0.29x | MX$10.26 Billion | MX$3.02 Billion | ▲ +93.2% |
| 2022 | 0.15x | MX$10.53 Billion | MX$1.61 Billion | ▲ +8.5% |
| 2021 | 0.14x | MX$10.52 Billion | MX$1.48 Billion | ▼ -16.9% |
| 2020 | 0.17x | MX$7.42 Billion | MX$1.25 Billion | ▼ -1.4% |
| 2019 | 0.17x | MX$7.71 Billion | MX$1.32 Billion | ▼ -32.8% |
| 2018 | 0.26x | MX$5.55 Billion | MX$1.42 Billion | ▲ +35.6% |
| 2017 | 0.19x | MX$7.38 Billion | MX$1.39 Billion | ▼ -29.2% |
| 2016 | 0.27x | MX$7.84 Billion | MX$2.08 Billion | ▲ +97.1% |
| 2015 | 0.13x | MX$8.92 Billion | MX$1.20 Billion | ▼ -28.6% |
| 2014 | 0.19x | MX$7.69 Billion | MX$1.45 Billion | ▲ +0.6% |
| 2013 | 0.19x | MX$6.95 Billion | MX$1.31 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow